Carregant...
Selecting treatment options in refractory metastatic colorectal cancer
Survival of patients with metastatic colorectal cancer (mCRC) has significantly improved in the last decade. Survival gains are not driven by advances in first-line therapy but by incremental additional effects of subsequent treatment lines. To maximize outcomes, patients should receive all active a...
Guardat en:
| Publicat a: | Onco Targets Ther |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Dove Medical Press
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6441549/ https://ncbi.nlm.nih.gov/pubmed/30988631 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S194605 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|